Integer Holdings Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Integer Holdings Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,387	1,462	1,215	1,258	1,073	1,221	1,331	1,556	1,717	1,854
Cost of revenue	738	782	852	903	788	884	986	1,146	1,258	1,353
Gross profit	338	354	363	355	286	337	346	410	459	500
Research and development	47.9	48.9	48.6	46.5	48.5	52	59.8	62	53.4	49.5
Selling, general and administrative	136	143	142	139	109	141	158	173	185	212
Operating expenses	245	228	207	197	165	201	233	247	251	279
Operating income	92.9	126	156	158	121	136	113	163	208	221
Interest expense	68.3	64	99.3	52.5	38.2	31.6	38.6	53.4	56.4	43.2
Other non-operating income	4.41	-10.9	-0.75	0.58	-1.52	0.12	0.9	-0.98	-3.52	-53.2
Pre-tax income	28.2	49.3	61.1	105	86.2	101	68.7	105	148	125
Income tax	3.29	-37.8	14.1	14	8.95	8.04	8.93	16.2	26.5	22.6
Income from continuing operations	24.9	87.1	47	91.2	77.3	93	59.7	89.1	121	103
Net income	5.96	66.7	168	96.3	77.3	96.8	66.4	90.7	120	103
EBITDA	183	228	245	236	200	217	205	262	319	352
EPS, basic	0.19	2.12	5.23	2.95	2.35	2.93	2.00	2.72	3.57	2.96
EPS, diluted	0.19	2.08	5.15	2.92	2.33	2.91	1.99	2.69	3.36	2.89
Shares, basic (weighted)	30.8	31.4	32.1	32.6	32.8	33	33.1	33.3	33.6	34.7
Shares, diluted (weighted)	31	32.1	32.6	33	33.1	33.3	33.4	33.8	35.6	35.6

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	52.1	44.1	25.6	13.5	49.2	17.9	24.3	23.7	46.5	17.2
Receivables	205	195	186	192	156	182	224	231	245	346
Inventory	225	177	190	167	149	156	209	229	247	254
Other current assets	22	16.2	15.1	17.9	15.9	27.6	27	30	28.4	40.6
Total current assets	517	532	416	415	413	453	558	618	671	770
Property, plant and equipment	372	235	231	246	254	277	317	393	466	536
Lease right-of-use assets				42.4	45.2	70.1	74.8	81.3	86.1	98.4
Goodwill	967	840	832	840	859	925	965	994	1,018	1,111
Intangible assets	940	863	812	776	757	808	820	780	778	825
Other non-current assets	31.8	30.4	30.5	29.3	38.7	35.8	26.9	22.4	23	23.2
Total assets	2,833	2,848	2,327	2,353	2,372	2,582	2,794	2,943	3,078	3,411
Accounts payable	77.9	64.6	57.2	65	51.6	76.9	111	118	101	113
Accrued liabilities	72.3	60.4	60.5	66.1	56.8	56.9	73.5	90.6	108	110
Deferred revenue		2.2	2.48	1.98	2.5	3.78	5.62	6.14	4.44	5.21
Short-term debt	31.3	30.5	37.5	37.5	37.5	15.3	18.2	0	10	0
Total current liabilities	185	209	165	179	156	160	224	221	227	232
Long-term debt	1,699	1,579	888	777	694	813	907	960	980	1,185
Lease liabilities			0	37.1	37.9	59.8	64	72.1	77.7	81.9
Other non-current liabilities	14.7	11.3	9.7	19.2	30.7	16.3	13.4	14.3	25.4	19.9
Total liabilities	2,107	1,955	1,266	1,201	1,101	1,228	1,377	1,424	1,459	1,664
Total debt	1,730	1,609	926	815	731	828	925	960	990	1,185
Paid-in capital	638	670	691	701	701	713	731	727	742	771
Retained earnings	109	176	344	440	518	614	681	771	891	994
Treasury stock	-5.83	-4.65	-8.13	-8.81	0			0	0	-76.9
Other comprehensive income	-16	52.2	33	20	52.7	27.2	5.33	20.2	-14	58.2
Shareholders' equity	725	893	1,060	1,152	1,271	1,355	1,417	1,519	1,619	1,747
Total equity	725	893	1,060	1,152	1,271	1,355	1,417	1,519	1,619	1,747
Total liabilities and equity	2,833	2,848	2,327	2,353	2,372	2,582	2,794	2,943	3,078	3,411
Shares outstanding	30.9	31.9	32.5	32.7	32.9	33.1	33.2	33.3	33.5	34.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	5.96	66.7	168	96.3	77.3	96.8	66.4	90.7	120	103
Depreciation and amortization	90.5	103	89	77.9	79.3	81.4	92	98.8	111	131
Stock-based compensation	8.41	14.7	10.5	9.29	9.16	16.2	21	23.3	24.8	23.2
Deferred income tax	-7.35	-44.8	4.35	-10.3	-6.97	-10.3	-17.5	-9.49	-14.1	-2.69
Change in receivables	-2.17	-34.6	9.29	-6.98	38.2	-17.5	-41.4	-7.44	-6.53	-82.4
Change in inventory	22.2	-0.99	-16.1	3.72	18.4	4.7	-56.7	-30.2	-18.1	-2.58
Change in payables	-1.13	4.89	-0.09	1.89	-9.06	19.5	26	-0.52	-16.6	-0.57
Cash from operations	106	149	167	165	181	157	116	180	205	196
Capital expenditures	-58.6	-47.3	-44.9	-48.2	-46.8	-53.5	-74.7	-120	-105	-91
Acquisitions	0	0	0	-15	-5.22	-218	-127	-43.6	-139	-179
Cash from investing	-63.3	-47.9	537	-58.9	-56.6	-271	-200	-163	-195	-271
Debt issued	57	50	5	0	0	818	0	486	0	978
Debt repaid	-46	-179	-705					-416	-0.01	-668
Stock issued	2.82	19.3	12.4	3.24	3.26	0.74	0.15	2.3	0.74	3.64
Share buybacks								0	0	-50
Cash from financing	-72.1	-112	-725	-118	-88.6	82	92.5	-18	13.3	43.6
Exchange rate effect	-0.45	2.23	2.58	-0.6	-0.52	1.03	-2.05	0.57	-0.24	1.64
Net change in cash	-30.4	-8.02	-18.5	-12	35.7	-31.3	6.39	-0.6	22.9	-29.4
Free cash flow	46.9	102	122	117	135	103	41.7	60.3	99.8	105
Interest paid	106	93.8	79.7	44.8	33.9	24.7	35.8	37.7	54.2	32.4
Income taxes paid	7.26	-8.19	23.2	30	18.5	19.6	11.2	30.4	36.5	28.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 3, 2026; growth uses fiscal years. Valuation uses the share price of $126.34 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	25.7%	Gross profit / revenue.
Operating margin	9.7%	Operating income / revenue.
EBITDA margin	17.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.4%	Pre-tax income / revenue.
Net margin	7.0%	Net income / revenue.
FCF margin	6.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.1%	Cash from operations / revenue.
Effective tax rate	5.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	7.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.8%	Net income / average total assets.
Return on invested capital (ROIC)	5.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.6%	Research and development expense / revenue.
SG&A / revenue	12.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	5.1%	Capital expenditures / revenue.
D&A / revenue	7.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	11.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	11.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	9.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	25.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	12.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	10.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	19.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	12.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-14.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	15.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	5.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-14.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	13.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	4.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-4.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	19.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	5.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	36.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-4.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	6.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	7.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.73x	Current assets / current liabilities.
Quick ratio	1.66x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.10x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.72x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	36.2%	Total debt / total assets.
Liabilities / assets	49.8%	Total liabilities / total assets.
Net debt	$1.22B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.84x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	4.64x	Operating income / interest expense.
Working capital	$593.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	55.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$174.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.54x	Revenue / average total assets.
Fixed asset turnover	3.46x	Revenue / average property, plant and equipment.
Inventory turnover	4.76x	Cost of revenue / average inventory.
Days inventory	77 days	365 x average inventory / cost of revenue.
Receivables turnover	5.44x	Revenue / average receivables.
Days sales outstanding	67 days	365 x average receivables / revenue.
Days payables	30 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	114 days	Days inventory + days sales outstanding - days payables.
FCF conversion	87.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	45.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.76	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$53.99	Revenue / diluted weighted shares.
FCF per share	$3.28	Free cash flow / diluted weighted shares.
Operating cash flow per share	$6.02	Cash from operations / diluted weighted shares.
Book value per share	$50.56	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$5.14	Tangible book value / shares outstanding.
Cash per share	$0.63	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$4.29B	Share price x shares outstanding.
Enterprise value	$5.51B	Market cap + total debt - cash - short-term investments.
P/E	33.4x	Market cap / net income. Only when net income is positive.
P/S	2.33x	Market cap / revenue.
P/B	2.50x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	38.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	20.9x	Market cap / cash from operations, when positive.
EV/Sales	2.99x	Enterprise value / revenue.
EV/EBIT	30.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	17.4x	Enterprise value / EBITDA, when both are positive.
EV/FCF	49.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.6%	Free cash flow / market cap.
Earnings yield	3.0%	Net income / market cap (the inverse of P/E).
PEG	2.53x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Integer Holdings Corp's revenue in fiscal 2025?

Integer Holdings Corp reported revenue of $1.85B for fiscal 2025, 8% higher than the year before.

Was Integer Holdings Corp profitable in fiscal 2025?

Yes. Net income was $102.8M, a net margin of 5.5%.

How much free cash flow did Integer Holdings Corp generate in fiscal 2025?

Cash from operations of $196.1M minus capital expenditures of $91.0M left free cash flow of $105.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Integer Holdings Corp